1. Home
  2. EPAC vs MNKD Comparison

EPAC vs MNKD Comparison

Compare EPAC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPAC
  • MNKD
  • Stock Information
  • Founded
  • EPAC 1910
  • MNKD 1991
  • Country
  • EPAC United States
  • MNKD United States
  • Employees
  • EPAC N/A
  • MNKD N/A
  • Industry
  • EPAC Industrial Machinery/Components
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPAC Technology
  • MNKD Health Care
  • Exchange
  • EPAC Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • EPAC 2.1B
  • MNKD 1.7B
  • IPO Year
  • EPAC N/A
  • MNKD 2004
  • Fundamental
  • Price
  • EPAC $41.71
  • MNKD $5.47
  • Analyst Decision
  • EPAC Strong Buy
  • MNKD Strong Buy
  • Analyst Count
  • EPAC 2
  • MNKD 5
  • Target Price
  • EPAC $50.50
  • MNKD $10.80
  • AVG Volume (30 Days)
  • EPAC 353.9K
  • MNKD 4.7M
  • Earning Date
  • EPAC 10-15-2025
  • MNKD 11-05-2025
  • Dividend Yield
  • EPAC 0.10%
  • MNKD N/A
  • EPS Growth
  • EPAC 8.66
  • MNKD 149.32
  • EPS
  • EPAC 1.70
  • MNKD 0.11
  • Revenue
  • EPAC $616,899,000.00
  • MNKD $301,736,000.00
  • Revenue This Year
  • EPAC $6.18
  • MNKD $14.78
  • Revenue Next Year
  • EPAC $5.63
  • MNKD $19.36
  • P/E Ratio
  • EPAC $24.54
  • MNKD $51.20
  • Revenue Growth
  • EPAC 4.65
  • MNKD 21.48
  • 52 Week Low
  • EPAC $36.51
  • MNKD $3.38
  • 52 Week High
  • EPAC $51.91
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • EPAC 52.86
  • MNKD 53.22
  • Support Level
  • EPAC $41.29
  • MNKD $5.24
  • Resistance Level
  • EPAC $42.48
  • MNKD $5.67
  • Average True Range (ATR)
  • EPAC 1.20
  • MNKD 0.21
  • MACD
  • EPAC 0.08
  • MNKD -0.01
  • Stochastic Oscillator
  • EPAC 48.27
  • MNKD 73.84

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: